Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY(2024)